A

Givinostat Effects on DMD Pathogenesis

Neuropediatrics, vol. 55, pp. S1–S25

Abstract

Background/Purpose: Givinostat is an HDAC inhibitor developed for the treatment of DMD. The Givinostat phase 3 study in DMD (Epidys) met its primary endpoint with consistent results in the key secondary endpoints. Givinostat’s mechanism of action (MoA) was elucidated in preclinical and clinical studies. Methods: Givinostat effects on muscle fibers integrity and necrosis, inflammation, muscle regeneration and fibroadipogenic replacement were studied in muscle biopsies in DMD mouse models and in DMD boys. Fatty replacement of the thigh was studied using magnetic resonance (MR) analysis in DMD boys in the phase 3 (Epidys) study, as well as circulating biomarkers of fibrosis (TGFbeta) and inflammation (IP10). Results: Givinostat improved myofiber cell membrane integrity (mouse) and reduced muscle cell necrosis (mouse, DMD boys). Givinostat anti-inflammatory effects were shown both in mouse and DMD boys. Givinostat increased muscle satellite cells and muscle regeneration fibers in muscle biopsies of DMD boys. Givinostat reduction of fibrosis was shown in muscle biopsies (mouse, DMD boys) and confirmed by the reduction of circulating TGFbeta in DMD boys. Givinostat reduction of fatty replacement was shown both in muscle biopsies (mouse, DMD boys) and in MR thigh scans (DMD boys). Conclusion: Givinostat was shown to counteract the pathogenetic events downstream of the lack of dystrophin both in the DMD mouse model and in DMD boys. Combined, these effects result in reduced muscle deterioration. Publication History Article published online: 08 October 2024 Georg Thieme Verlag KG Stuttgart · New York

Authors 8

  1. Italfarmaco (Italy)

    Affiliation as printed

    Italfarmaco Spa, Milano, Italy

  2. Saint Camillus International University of Health and Medical Sciences

    Affiliation as printed

    Unicamillus International Medical University in Rome, Rome, Italy

  3. Bambino Gesù Children's Hospital

    Affiliation as printed

    Confocal Microscopy Core Facility, Ospedale Pediatrico Bambino Gesù, Rome, Italy

  4. University of Florida

    Affiliation as printed

    Department of Physical Therapy, University of Florida, Gainesville, Florida, United States

  5. Italfarmaco (Italy)

    Affiliation as printed

    Italfarmaco Spa, Milano, Italy

  6. Italfarmaco (Italy)

    Affiliation as printed

    Italfarmaco Spa, Milano, Italy

  7. Sanford Burnham Prebys Medical Discovery Institute

    Affiliation as printed

    Department of Human Development, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States

  8. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

Cited by 1 stored of 1

1 result

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0